UK opposition urges payment only for drugs that work
This article was originally published in Scrip
Executive Summary
The UK's main opposition party has called for pharmaceutical companies to be paid according to the benefits that their products bring to patients. It says the current system of price controls and profit caps is outdated, and its criticism echoes the principal conclusions of an Office of Fair Trading report last year that pharmaceutical prices should be determined by value.